person · Reporting owner

Kardaras Constantine John

Disclosed activity across 1 company

Tapewire entity: 126182
SEC CIK: 0001899660

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Imunon, Inc.CLSN · Entity 8041	Chief Accounting Officer	June 13, 2022	June 15, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Imunon, Inc.

Report date June 13, 2022 · Filed June 15, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Option to Purchase Celsion Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.93 · Expires 2032-06-13	Direct	5,833	Reported balance After 2022-06-13 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-06-13 · Grant · Acquired 1,750 · Balance 5,833 F1: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant.

F2: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 13, 2022 Filed Jun 15, 2022 20:55 UTC	Imunon, Inc. CLSN · Entity 8041	GrantOption to Purchase Celsion Common Stock · Derivative	1,750	$0.00 Strike: $1.93	$0.00	Disclosure SEC source: 0001437749-22-015078 · rdgdoc.xml · derivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833 Underlying: Celsion Corporation Common Stock · 1,750 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document
March 04, 2022 Filed Mar 7, 2022 23:07 UTC	Imunon, Inc. CLSN · Entity 8041	GrantOption to Purchase Celsion Common Stock · Derivative	1,750	$0.00 Strike: $4.60	$0.00	Disclosure SEC source: 0001437749-22-005440 · rdgdoc.xml · derivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,083 Underlying: Celsion Corporation Common Stock · 1,750 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document
December 14, 2021 Filed Dec 16, 2021 21:42 UTC	Imunon, Inc. CLSN · Entity 8041	GrantOption to Purchase Celsion Corporation Common Stock · Derivative	35,000	$0.63 Strike: $0.63	$22,050.00	Disclosure SEC source: 0001437749-21-028762 · rdgdoc.xml · derivative · entry 2 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Celsion Corporation Common Stock · 35,000 shares Expires 2031-12-14 F3 · derivative.exercise_price: Represents the per share fair value of the common stock based on the closing price of a share of Celsion Common Stock on the date of the award. F3 · price: Represents the per share fair value of the common stock based on the closing price of a share of Celsion Common Stock on the date of the award. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant. Read SEC document
December 14, 2021 Filed Dec 16, 2021 21:42 UTC	Imunon, Inc. CLSN · Entity 8041	GrantCelsion Corporation Common Stock	10,000	$0.00	$0.00	Disclosure SEC source: 0001437749-21-028762 · rdgdoc.xml · nonDerivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: Stock grant award which will vest on the first anniversary of hire date (December 6, 2022). Fair value of the stock award is $0.63 per share based on the closing price of Celsion Common Stock the award date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.